BRUNETTI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 836
EU - Europa 500
AS - Asia 384
Totale 1.720
Nazione #
US - Stati Uniti d'America 833
IT - Italia 205
IE - Irlanda 161
SG - Singapore 100
CN - Cina 86
HK - Hong Kong 76
VN - Vietnam 75
KR - Corea 38
RU - Federazione Russa 27
UA - Ucraina 22
DE - Germania 19
FI - Finlandia 17
SE - Svezia 15
CH - Svizzera 8
BE - Belgio 5
AT - Austria 4
FR - Francia 4
CZ - Repubblica Ceca 3
GB - Regno Unito 3
JP - Giappone 3
NL - Olanda 3
ES - Italia 2
IL - Israele 2
UZ - Uzbekistan 2
BG - Bulgaria 1
CA - Canada 1
GT - Guatemala 1
LB - Libano 1
MX - Messico 1
RO - Romania 1
TR - Turchia 1
Totale 1.720
Città #
Chandler 208
Dublin 161
Perugia 104
San Mateo 85
Hong Kong 76
Dong Ket 75
Singapore 71
Boardman 64
Seoul 38
Wilmington 38
Medford 35
Princeton 33
Beijing 32
Altamura 31
Lawrence 30
Andover 24
Falls Church 16
Redwood City 16
Los Angeles 12
Redmond 12
Rome 11
Saint Petersburg 11
Ann Arbor 10
Norwalk 10
Des Moines 9
Helsinki 9
Munich 6
San Paolo di Civitate 6
Shanghai 6
Brussels 5
Chicago 4
Jacksonville 4
Santa Clara 4
Torino 4
Ashburn 3
Cambridge 3
Dallas 3
Frankfurt Am Main 3
Tokyo 3
Basel 2
Campobasso 2
Collazzone 2
Gijón 2
Houston 2
Lausanne 2
Nanjing 2
Nepi 2
Northvale 2
Sant'ilario D'enza 2
Tappahannock 2
Todi 2
Zhengzhou 2
Acireale 1
Amsterdam 1
Ancona 1
Arezzo 1
Belgioioso 1
Brno 1
Dearborn 1
Evanston 1
Foligno 1
Gatchina 1
Groningen 1
Guatemala City 1
Izmir 1
Jinan 1
Kunming 1
Lappeenranta 1
Mainz 1
Mexico City 1
Milan 1
Mississauga 1
Modesto 1
Nanning 1
Olomouc 1
Omsk 1
Paris 1
Perm 1
Pitesti 1
Ponzano Veneto 1
Prineville 1
San Diego 1
St Petersburg 1
Tampa 1
Tianjin 1
Tong 1
Umbertide 1
Vienna 1
Wuhan 1
Totale 1.338
Nome #
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 105
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 91
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 81
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 68
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A 67
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia 66
Mutant NPM1 Maintains the Leukemic State through HOX Expression 65
Aerobic Plus Resistance Exercise in Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Weight Loss 64
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression 59
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 58
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9 57
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 54
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 54
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 53
DNMT3A in Leukemia 49
How I diagnose and treat NPM1-mutated AML 48
CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells: Correspondence 47
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice 47
Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma 44
NPM1-mutated acute myeloid leukemia: from bench to bedside 43
TFEB regulates murine liver cell fate during development and regeneration 41
Highly efficient gene disruption of murine and human hematopoietic progenitor cells by CRISPR/Cas9 40
Dissecting the Hierarchical Level of Hematopoietic Progenitors' Involvement in AML with NPM1 Gene Mutation and Their Engraftment Potential in Immunocompromised Mice. 38
Effect of the COVID-19 Pandemic on Laboratory and Clinical Research: A Testimony and a Call to Action From Researchers 36
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 36
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 34
Nutrient-sensitive transcription factors TFEB and TFE3 couple autophagy and metabolism to the peripheral clock 33
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells 33
Response to: “Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” 32
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 29
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics 29
New insights into the biology of acute myeloid leukemia with mutated NPM1 29
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1 27
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion 26
Current status and future perspectives in targeted therapy of NPM1-mutated AML 24
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 24
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 23
Overlapping features of therapy-related and de novoNPM1-mutated AML 21
null 18
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 14
NPM1-mutated AML with starry sky pattern 12
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis 11
Totale 1.830
Categoria #
all - tutte 8.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202071 0 0 0 0 5 1 1 7 16 36 5 0
2020/2021241 0 3 11 7 79 12 5 31 13 4 1 75
2021/2022383 5 77 1 6 20 16 7 77 12 45 62 55
2022/2023622 36 107 10 57 54 67 1 30 216 11 26 7
2023/2024284 12 31 11 8 1 8 66 2 17 23 47 58
2024/2025174 47 53 27 38 9 0 0 0 0 0 0 0
Totale 1.830